Heavy metals in MS

In a new study published recently, tissue from the MS Research Australia Brain Bank was used. Led by Associate Professor Roger Pamphlett from the University of Sydney, to study the role of heavy metal accumulation in the spinal cord of people with MS and other neurodegenerative disorders.

Motor neurons, the cells in the brain and spinal cord that control muscle function and movement, can be injured and lost in MS and often in areas not affected by lesions. One factor that may contribute to this loss is the uptake of toxic substances from the environment such as heavy metals like mercury or silver.

The research used a technique called autometallography which allows researchers to see whether heavy metals are present within cells. Associate Professor Pamphlett examined spinal cord tissue samples from people with MS, as well as people who did not have any evidence of motor neuron damage. He found that heavy metals were present in motor neurons and also in a special class of nerve cells called interneurons, which relay electrical signals between different types of nerve cells.

It was found that in the normal ageing process heavy metals accumulate in nerve cells. However, if this accumulation was too great, or if people had other risk factors it may contribute to the loss of neurons. In particular, damage to interneuron types of cells can lead to nerve loss, as these cells normally help protect nerve cells, but removing interneurons short circuits this protection leading to nerve cell loss.

The use of tissue from people with MS is key to the success of this study, as only examining nerve cells from the spinal cord, in this case, can help answer the question of whether heavy metals or other environmental toxins are having an impact on MS and other neurodegenerative disorders.

If you would like more information about the MS Research Australia Brain Bank or would like to register to become a brain donor please phone 1300 672 265 or register online at


New campaign shines light on life-changing MS Nurse Care

MS Australia has today launched a new campaign at Parliament House on World MS Day (30 May) to raise awareness of the crucial role played by MS Nurses.

Revolutionising MS Treatment: New form of Tysabri® recommended for PBS listing

The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the listing of natalizumab (Tysabri®) pre-filled syringe for subcutaneous (under the skin) injection on the Pharmaceutical Benefit Scheme (PBS).

What us to keep you in the loop? Subscribe today!

  • Enter your details

Read More

Newsletter subscription

  • Enter your details

Heavy metals in MS